Sweden
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 441.19 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
2 |
USD 226.27 M
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
3 |
USD 220.50 M
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
4 |
USD 185.49 M
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
5 |
USD 169.17 M
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
6 |
USD 76.30 M
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
7 |
USD 74.72 M
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
8 |
USD 61.29 M
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
9 |
USD 59.90 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
10 |
USD 30.57 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
11 |
USD 19.39 M
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
12 |
USD 17.27 M
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
13 |
USD 11.04 M
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
14 |
USD 6.69 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
15 |
USD 5.20 M
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
16 |
USD 5.07 M
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
17 |
USD 4.57 M
|
Dec. 31, 2023 | USD 41.47 | -0.80% |
|
Sweden |
|
18 |
USD 3.68 M
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
19 |
USD 2.26 M
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
20 |
USD 1.51 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
21 |
USD 905.87 K
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
22 |
USD 589.44 K
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
23 |
USD 301.73 K
|
Dec. 31, 2023 | USD 0.12 | -10.10% |
|
Sweden |
|
24 |
USD 134.39 K
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
25 |
USD 87.45 K
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
26 |
USD -29.91 K
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
27 |
USD -479.09 K
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
28 |
USD -1.50 M
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
29 |
USD -1.80 M
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
30 |
USD -1.84 M
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
31 |
USD -3.02 M
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
32 |
USD -3.11 M
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
33 |
USD -3.28 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
34 |
USD -3.54 M
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
35 |
USD -3.57 M
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
36 |
USD -3.66 M
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
37 |
USD -3.76 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
38 |
USD -3.81 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
39 |
USD -3.98 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
40 |
USD -4.52 M
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
41 |
USD -9.38 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
42 |
USD -9.89 M
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
43 |
USD -10.37 M
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
44 |
USD -11.24 M
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
|
45 |
USD -12.51 M
|
Dec. 31, 2023 | USD 0.26 | -2.13% |
|
Sweden |
|
46 |
USD -12.52 M
|
Aug. 31, 2024 | USD 1.49 | -4.08% |
|
Sweden |
|
47 |
USD -16.06 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
48 |
USD -16.27 M
|
Dec. 31, 2023 | USD 1.30 | -5.64% |
|
Sweden |
|
49 |
USD -20.06 M
|
Dec. 31, 2023 | USD 3.06 | 1.23% |
|
Sweden |
|
50 |
USD -24.63 M
|
Dec. 31, 2023 | USD 0.79 | -2.96% |
|
Sweden |
The Healthcare company in Sweden with the highest Operating Cash Flow is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 441.19 M.
The Healthcare company in Sweden with the lowest Operating Cash Flow is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at USD -74.58 M.
The top 10 Healthcare companies in Sweden by Operating Cash Flow are Swedish Orphan Biovitrum AB (publ), Medicover AB (publ), Attendo AB (publ), Arjo AB (publ), Ambea AB (publ), AddLife AB (publ), Vitrolife AB (publ), Humana AB (publ), Camurus AB (publ) and BioArctic AB (publ).
The bottom 10 Healthcare companies in Sweden by Operating Cash Flow are Hansa Biopharma AB (publ), BioInvent International AB (publ), Vimian Group AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), Xspray Pharma AB (publ), IRLAB Therapeutics AB (publ) and Mendus AB (publ).